Judge Trims SEC Fraud Case Over Cancer Drug Claims
By Carolyn Muyskens · March 25, 2026, 3:50 PM EDT
A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques"...
To view the full article, register now.